Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 2581 AL 2595

PUBMED

Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.

AlDakheel A, Kalia LV, Lang AE.

Neurotherapeutics. 2014 Jan;11(1):6-23. doi: 10.1007/s13311-013-0218-1. Review.

0

0

0

PUBMED

Lack of association of morphologic and functional retinal changes with motor and non-motor symptoms severity in Parkinson’s disease.

Cubo E, López Peña MJ, Diez-Feijo Varela E, Pérez Gil O, Garcia Gutierrez P, Araus González E, Prieto Tedejo R, Mariscal Pérez N, Armesto D.

J Neural Transm (Vienna). 2014 Feb;121(2):139-45.

0

0

0

PUBMED

Taste performance in Parkinson’s disease.

Cecchini MP, Osculati F, Ottaviani S, Boschi F, Fasano A, Tinazzi M.

J Neural Transm (Vienna). 2014 Feb;121(2):119-22.

0

0

0

PUBMED

Does Parkinson's disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?

Lima MM, Targa AD, Noseda AC, Rodrigues LS, Delattre AM, dos Santos FV, Fortes MH, Maturana MJ, Ferraz AC.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):418-28. Review.

0

0

0

PUBMED

Pharmacological prolyl hydroxylase domain inhibition as a therapeutic target for Parkinson's disease.

Rajagopalan S, Chinta SJ, Andersen JK.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):120-5.

0

0

0

PUBMED

Cerebrovascular profile assessment in Parkinson's disease patients.

Perju-Dumbravă L, Muntean ML, Muresanu DF.

CNS Neurol Disord Drug Targets. 2014;13(4):712-7.

0

0

0

PUBMED

Deep brain stimulation may improve quality of life in people with Parkinson's disease without affecting caregiver burden.

Oyama G, Okun MS, Schmidt P, Tröster AI, Nutt J, Go CL, Foote KD, Malaty IA; NPF-QII Investigators..

Neuromodulation. 2014 Feb;17(2):126-32.

0

0

0

PUBMED

Effects of 24 wk of treadmill training on gait performance in Parkinson's disease.

Nadeau A, Pourcher E, Corbeil P.

Med Sci Sports Exerc. 2014 Apr;46(4):645-55. doi: 10.1249/MSS.0000000000000144.

0

0

0

PUBMED

Identification of three novel LRRK2 mutations associated with Parkinson's disease in a Calabrian population.

Anfossi M, Colao R, Gallo M, Bernardi L, Conidi ME, Frangipane F, Vasso F, Puccio G, Clodomiro A, Mirabelli M, Curcio SA, Torchia G, Smirne N, Di Lorenzo R, Maletta R, Bruni AC.

J Alzheimers Dis. 2014;38(2):351-7. doi: 10.3233/JAD-130689.

0

0

0

PUBMED

Signaling pathways involved in 1-octen-3-ol-mediated neurotoxicity in Drosophila melanogaster: implication in Parkinson’s disease.

Inamdar AA, Masurekar P, Hossain M, Richardson JR, Bennett JW.

Neurotox Res. 2014 Feb;25(2):183-91. Erratum in: Neurotox Res. 2014 Feb;25(2):192.

0

0

0

PUBMED

3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.

Gunjima K, Tomiyama R, Takakura K, Yamada T, Hashida K, Nakamura Y, Konishi T, Matsugo S, Hori O.

J Cell Biochem. 2014 Jan;115(1):151-60. doi: 10.1002/jcb.24643.

0

0

0

PUBMED

Levodopa inhibits habit-learning in Parkinson’s disease.

Fuhrer H, Kupsch A, Hälbig TD, Kopp UA, Scherer P, Gruber D.

J Neural Transm (Vienna). 2014 Feb;121(2):147-51.

0

0

0

PUBMED

Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.

Zhou B, Yuan F, He Z, Tan C.

Brain Imaging Behav. 2014 Mar;8(1):97-101. doi: 10.1007/s11682-013-9251-2.

0

0

0

PUBMED

Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease.

Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I.

J Alzheimers Dis. 2014;38(1):63-73. doi: 10.3233/JAD-130995.

0

0

0

PUBMED

Fasciculation and elongation protein zeta-1 (FEZ1) expression in reactive astrocytes in a rat model of Parkinson's disease.

Sun YY, Zhang Y, Sun XP, Liu TY, Liu ZH, Chen G, Xia CL.

Neuropathol Appl Neurobiol. 2014 Feb;40(2):164-76. doi: 10.1111/nan.12077.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy